» Articles » PMID: 30672691

Thrombin Exosite Maturation and Ligand Binding at ABE II Help Stabilize PAR-Binding Competent Conformation at ABE I

Overview
Journal Biochemistry
Specialty Biochemistry
Date 2019 Jan 24
PMID 30672691
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Thrombin, derived from zymogen prothrombin (ProT), is a serine protease involved in procoagulation, anticoagulation, and platelet activation. Thrombin's actions are regulated through anion-binding exosites I and II (ABE I and ABE II) that undergo maturation during activation. Mature ABEs can utilize exosite-based communication to fulfill thrombin functions. However, the conformational basis behind such long-range communication and the resultant ligand binding affinities are not well understood. Protease activated receptors (PARs), involved in platelet activation and aggregation, are known to target thrombin ABE I. Unexpectedly, PAR3 (44-56) can already bind to pro-ABE I of ProT. Nuclear magnetic resonance (NMR) ligand-enzyme titrations were used to characterize how individual PAR1 (49-62) residues interact with pro-ABE I and mature ABE I. 1D proton line broadening studies demonstrated that binding affinities for native PAR1P (49-62, P54) and for the weak binding variant PAR1G (49-62, P54G) increased as ProT was converted to mature thrombin. H,N-HSQC titrations revealed that PAR1G residues K51, E53, F55, D58, and E60 exhibited less affinity to pro-ABE I than comparable residues in PAR3G (44-56, P51G). Individual PAR1G residues then displayed tighter binding upon exosite maturation. Long-range communication between thrombin exosites was examined by saturating ABE II with phosphorylated GpIbα (269-282, 3Yp) and monitoring the binding of PAR1 and PAR3 peptides to ABE I. Individual PAR residues exhibited increased affinities in this dual-ligand environment supporting the presence of interexosite allostery. Exosite maturation and beneficial long-range allostery are proposed to help stabilize an ABE I conformation that can effectively bind PAR ligands.

Citing Articles

Structural Insights into Protein-Aptamer Recognitions Emerged from Experimental and Computational Studies.

Troisi R, Balasco N, Autiero I, Vitagliano L, Sica F Int J Mol Sci. 2023; 24(22).

PMID: 38003510 PMC: 10671752. DOI: 10.3390/ijms242216318.


Thrombin in complex with dabigatran can still interact with PAR-1 via exosite-I and instigate loss of vascular integrity.

Dolleman S, Agten S, Spronk H, Hackeng T, Bos M, Versteeg H J Thromb Haemost. 2022; 20(4):996-1007.

PMID: 35037739 PMC: 9306515. DOI: 10.1111/jth.15642.


Exosite Binding in Thrombin: A Global Structural/Dynamic Overview of Complexes with Aptamers and Other Ligands.

Troisi R, Balasco N, Autiero I, Vitagliano L, Sica F Int J Mol Sci. 2021; 22(19).

PMID: 34639143 PMC: 8509272. DOI: 10.3390/ijms221910803.

References
1.
Gandhi P, Chen Z, Di Cera E . Crystal structure of thrombin bound to the uncleaved extracellular fragment of PAR1. J Biol Chem. 2010; 285(20):15393-15398. PMC: 2865304. DOI: 10.1074/jbc.M110.115337. View

2.
Pozzi N, Chen Z, Zapata F, Niu W, Barranco-Medina S, Pelc L . Autoactivation of thrombin precursors. J Biol Chem. 2013; 288(16):11601-10. PMC: 3630838. DOI: 10.1074/jbc.M113.451542. View

3.
Kamath L, Meydani A, Foss F, Kuliopulos A . Signaling from protease-activated receptor-1 inhibits migration and invasion of breast cancer cells. Cancer Res. 2001; 61(15):5933-40. View

4.
Gandhi P, Chen Z, Appelbaum E, Zapata F, Di Cera E . Structural basis of thrombin-protease-activated receptor interactions. IUBMB Life. 2011; 63(6):375-82. DOI: 10.1002/iub.461. View

5.
Celikel R, McClintock R, Roberts J, Mendolicchio G, Ware J, Varughese K . Modulation of alpha-thrombin function by distinct interactions with platelet glycoprotein Ibalpha. Science. 2003; 301(5630):218-21. DOI: 10.1126/science.1084183. View